COVID-19 Seroprevalence Study in French Guiana (EPI-COVID-POP)
Sponsor: Centres Délocalisés de Prévention et de Soins, Centre Hospitalier Andrée Rosemon de Cayenne, Frech Guiana
This NA trial investigates Coronavirus Infection and Covid19 and is currently completed. Centres Délocalisés de Prévention et de Soins, Centre Hospitalier Andrée Rosemon de Cayenne, Frech Guiana leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2021 — Mar 2022 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Jul 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centres Délocalisés de Prévention et de Soins, Centre Hospitalier Andrée Rosemon de Cayenne, Frech Guiana
- Eurofins
- Institut Pasteur
- Institut Pasteur de la Guyane
- Laboratoire de biologie médicale de Kourou, French Guiana
- Laboratoire de biologie médicale du Centre hospitalier de Saint-Laurent du Maroni, French Guiana
- Laboratoire de biologie médicale, Institut Pasteur de la Guyane
For direct contact, visit the study record on ClinicalTrials.gov .